Hair Loss
Hair-loss research targets androgenic alopecia (DHT-driven follicle miniaturization) and other follicle-dystrophic processes. GHK-Cu enlarges hair follicles and prolongs the anagen growth phase in rodent models. Community-reported research protocols cite topical and intradermal applications; no FDA-approved use in hair loss.
